That analysis showed lower PAX7, MYF5, and MRF4 levels in ARMS subtype than in ERMS, whereas higher levels of PAX3, MYOD, SIX1, and SIX4 (Figure 9A). This evidence concerns the gene PAX7 and embryonal rhabdomyosarcoma.